- Home
- BELFB vs ANIP Comparison
BELFB vs ANIP Comparison
Compare BELFB & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- ANIP
- Stock Information
- Founded
- BELFB 1949
- ANIP 2001
- Country
- BELFB United States
- ANIP United States
- Employees
- BELFB N/A
- ANIP N/A
- Industry
- BELFB
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- BELFB
- ANIP Health Care
- Exchange
- BELFB Nasdaq
- ANIP Nasdaq
- Market Cap
- BELFB 1.1B
- ANIP 1.2B
- IPO Year
- BELFB N/A
- ANIP N/A
- Fundamental
- Price
- BELFB $73.70
- ANIP $67.51
- Analyst Decision
- BELFB Strong Buy
- ANIP Strong Buy
- Analyst Count
- BELFB 3
- ANIP 8
- Target Price
- BELFB $100.00
- ANIP $79.75
- AVG Volume (30 Days)
- BELFB 91.0K
- ANIP 374.9K
- Earning Date
- BELFB 04-24-2025
- ANIP 05-09-2025
- Dividend Yield
- BELFB 0.38%
- ANIP N/A
- EPS Growth
- BELFB N/A
- ANIP N/A
- EPS
- BELFB 3.25
- ANIP N/A
- Revenue
- BELFB $534,792,000.00
- ANIP $614,376,000.00
- Revenue This Year
- BELFB $22.35
- ANIP $26.80
- Revenue Next Year
- BELFB $5.36
- ANIP $6.89
- P/E Ratio
- BELFB $22.64
- ANIP N/A
- Revenue Growth
- BELFB N/A
- ANIP 26.20
- 52 Week Low
- BELFB $53.74
- ANIP $52.50
- 52 Week High
- BELFB $92.61
- ANIP $70.00
- Technical
- Relative Strength Index (RSI)
- BELFB 39.48
- ANIP 65.98
- Support Level
- BELFB $75.86
- ANIP $62.96
- Resistance Level
- BELFB $78.70
- ANIP $69.33
- Average True Range (ATR)
- BELFB 2.70
- ANIP 2.25
- MACD
- BELFB -0.04
- ANIP 0.37
- Stochastic Oscillator
- BELFB 26.92
- ANIP 77.07
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.